• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    16.37 Down 0.37(2.21%) Apr 17, 4:00PM EDT
    |After Hours : 16.37 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:16.74
    Open:16.58
    Bid:N/A
    Ask:17.46 x 100
    1y Target Est:23.50
    Beta:0.34
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:16.28 - 16.72
    52wk Range:11.80 - 18.86
    Volume:150,774
    Avg Vol (3m):138,540
    Market Cap:562.34M
    P/E (ttm):N/A
    EPS (ttm):-0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OSIR

    Comparison

    Symbol% ChgMkt Cap
    OSIRDown 2.21%562.34M
    ABTDown 0.58%69.79B
    BIIBDown 2.15%98.41B

    Key Statistics

    Forward P/E (1 yr):27.28
    P/S (ttm):9.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.31
    Quarterly EPS Est (Mar-15) :0.00
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback